SRZN
Price:
$9.15
Market Cap:
$29.74M
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Sur...[Read more]
Industry
Biotechnology
IPO Date
2021-01-11
Stock Exchange
NASDAQ
Ticker
SRZN
According to Surrozen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 250.67K. This represents a change of -110.76% compared to the average of -2329165.00 of the last 4 quarters.
The mean historical Enterprise Value of Surrozen, Inc. over the last ten years is 64.55M. The current 250.67K Enterprise Value has changed -61.17% with respect to the historical average. Over the past ten years (40 quarters), SRZN's Enterprise Value was at its highest in in the December 2020 quarter at 5.29B. The Enterprise Value was at its lowest in in the June 2023 quarter at -15427855.50.
Average
64.55M
Median
39.74M
Minimum
-13694800.00
Maximum
200.32M
Discovering the peaks and valleys of Surrozen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 139.72%
Maximum Annual Enterprise Value = 200.32M
Minimum Annual Increase = -1326.34%
Minimum Annual Enterprise Value = -13694800.00
Year | Enterprise Value | Change |
---|---|---|
2023 | -13694800.00 | -1326.34% |
2022 | 1.12M | -99.44% |
2021 | 200.32M | 110.27% |
2020 | 95.27M | 139.72% |
The current Enterprise Value of Surrozen, Inc. (SRZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
62.58M
5-year avg
64.55M
10-year avg
64.55M
Surrozen, Inc.’s Enterprise Value is less than Bolt Biotherapeutics, Inc. (30.96M), less than Larimar Therapeutics, Inc. (363.34M), less than Keros Therapeutics, Inc. (1.75B), less than Kezar Life Sciences, Inc. (36.78M), greater than Processa Pharmaceuticals, Inc. (15.28K), greater than NexImmune, Inc. (-1935978.00), less than Evelo Biosciences, Inc. (16.71M), less than Tempest Therapeutics, Inc. (35.14M), less than Replimune Group, Inc. (984.10M), less than Nuvectis Pharma, Inc. (81.37M), less than Lyra Therapeutics, Inc. (23.90M), less than Kronos Bio, Inc. (5.32M), less than Gossamer Bio, Inc. (331.04M), less than ERYTECH Pharma S.A. (20.24M), less than Aptorum Group Limited (5.11M), less than Unicycive Therapeutics, Inc. (23.47M), less than Armata Pharmaceuticals, Inc. (138.55M), less than CytomX Therapeutics, Inc. (39.67M), less than Instil Bio, Inc. (165.40M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Spero Therapeutics, Inc. (-8426888.00), less than Assembly Biosciences, Inc. (68.59M),
Company | Enterprise Value | Market cap |
---|---|---|
30.96M | $22.14M | |
363.34M | $393.05M | |
1.75B | $2.27B | |
36.78M | $54.72M | |
15.28K | $2.81M | |
-1935978.00 | $488.13K | |
16.71M | $28.47K | |
35.14M | $39.52M | |
984.10M | $1.02B | |
81.37M | $98.54M | |
23.90M | $12.37M | |
5.32M | $54.49M | |
331.04M | $157.63M | |
20.24M | $47.38M | |
5.11M | $3.83M | |
23.47M | $55.01M | |
138.55M | $81.41M | |
39.67M | $69.65M | |
165.40M | $170.65M | |
-6333315.00 | $8.20M | |
-8426888.00 | $63.24M | |
68.59M | $95.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surrozen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Surrozen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Surrozen, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Surrozen, Inc. (SRZN)?
What is the 3-year average Enterprise Value for Surrozen, Inc. (SRZN)?
What is the 5-year average Enterprise Value for Surrozen, Inc. (SRZN)?
How does the current Enterprise Value for Surrozen, Inc. (SRZN) compare to its historical average?